Age-related immune response to measles virus in staff of a large city hospital

The aims of the study were to examine age-related features of immune response to measles virus in staff of a large city hospital and to define groups at risk for measles outbreaks.

Methods. The study involved 1,855 staff members of a large city hospital aged ≥ 19 years old who had documented vaccination against measles or a history of measles. The participants were divided into age groups with 5-year intervals starting from 19 years of age; there were 11 groups in total. The immune response to measles virus was measured in sera by ELISA using Vector-Best IgG-Kor test system (Russia).

Results. Young employers of 19 to 23 years of age were most susceptible to measles; protective antibody level was not detected in 38.5% of them. They were followed by young-to-middle-aged workers (24 to 48 years old) who were negative for anti-measles antibodies or had non-protective level of antibodies in 16.7% to 27.5%. The anti-measles antibody level was low (42.3 % to 60.0 %) in employers of 19 to 43 years of age and gradually increased to 46.3% – 92.2% in the group of 44 to 68 years old.

Conclusion. Herd immunity against measles in employers of a large city hospital did not meet requirements for successful infection control which implicates ≤ 7% of seronegative individuals. This means that measles outbreak could occur at any time because the proportion of seronegative individuals (11.5%) twice exceeded the cut-off value; the antibody level was controversial in 3.2% of individuals. Therefore, monitoring anti-measles antibody level in hospital staff is necessary to detect groups at risk who should be vaccinated against measles.

1. Kostinov M.P., Balabolkin I.I., Ignat'eva G.V., Sadykova D.K. Clinical features of post-vaccination status and development of anti-measles defense in children with allergic disease. Pediatriya. Zhurnal im. G.N.Speranskogo. 1989, 68 (9): 33–38 (in Russian).

2. Kostinov M.P., Gervazieva V.B., Balabolkin I.I. Immune response after anti-measles vaccination of children with allergic disease. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 1990; 67 (3): 81–84 (in Russian).

3. Kostinov M.P., Ozeretskovskiy N.A., eds. Clinical and Immunological Efficacy of Immunobiological Agents: Handbook. Moscow: Miklosh; 2004 (in Russian).

4. Solov'eva I.L. Kostinov M.P., Kusel'man A.I. Vaccination against Hepatitis B, Measles, and Mumps in Children with Abnormal Preclinical Background. Ul'yanovsk: UlGU; 2006 (in Russian).

5. Polishchuk V.B., Ryzhov A.A., Kostinov M.P. Anti-measles immunity in patients waiting for lung transplantation. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2016; (4): 55–60 (in Russian).

6. Kostinov M.P., Balabolkin I.I., Gervazieva V.B., Ovsyannikova I.G. Measurement of the total immunoglobulin E before vaccination with live virus vaccine against measles in children with allergic diseases. Immunologiya. 1990; 11 (1): 41–44 (in Russian).

7. Kostinov M.P., ed. Vaccination of Children with Health Impairments: A Practical Handbook for Physicians. The 1st Edition. Moscow: Meditsina dlya vsekh; 1996 (in Russian).

8. Kostinov M.P., ed. News in Clinical Course, Diagnostics and Preventive Vaccination against Controlled Infections. Moscow: Meditsina; 1997.

9. Solov'eva I.L., Lezhen' E.M., Kusel'man A. I.et al. Vaccination of children with recurrent infections using Russian vaccine against mumps and measles. Ul'yanovskiy mediko-biologicheskiy zhurnal. 2013; (2): 20–25 (in Russian).

10. Kostinov M.P., ed. Vaccination of Children with Health Impairments: A Practical Handbook for Physicians. The 4th Edition. Moscow: 4Mpress; 2013 (in Russian).

11. Ibragimova E.M., Yuminova N.V., Kostinov M.P. et al. Certain aspects of herd immunity against measles, mumps and rubella in Primorskiy kray. Epidemiologiya i vaktsinoprofilaktika. 2005; 3 (22): 21–23 (in Russian).

12. Kostinov M.P., Shmit'ko A.D., Solov'eva I. L.et al. Are children with allergic diseases and children with recurrent infections protected against measles after revaccination? Pediatriya. Zhurnal im. G.N.Speranskogo. 2017; 96 (4): 140–145. DOI: 10.24110/0031-403X-2017-96-4-140-145.

13. Kostinov M.P., Shmit'ko A.D., Solov'eva I. L. et al. Is the third dose of anti-measles vaccine necessary? An immunologist`s view. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2016; (5): 88–94 (in Russian).

14. Kostinov M.P., ed. Vaccination of Children with Health Impairments: A Practical Handbook for Physicians. The 2nd Edition. Moscow: Meditsina dlya vsekh; 2000 (in Russian).

15. Kostinov M.P., Zverev V.V., eds. Vaccination of Adults with Chronic Diseases against Hepatitis B, Influenza and Rubella: A Practical Handbook. Moscow: MDV; 2009 (in Russian).

16. Zverev V.V., Khaitov R.M., eds. Vaccines and Vaccination: A National Handbook. Moscow: GEOTAR-Media; 2014 (in Russian).

17. Khaitov R.M., Il'ina N.I., eds. Allergology and Immunology: A National Handbook. Moscow: GEOTAR-Media; 2014 (in Russian).

18. Kostinov M.P., ed. Immune Therapy in Pediatrics: A Practical Handbook for Physicians. Moscow: Meditsina dlya vsekh; 1997 (in Russian).

19. Solov'eva I.L., Kusel'man A.I., Kostinov M.P., Anokhina E.V. A role of immunomodulating therapy in children before vaccination. Allergologiya i immunologiya. 2007; 8 (2): 207–208.

20. Afinogenova V.P., Lukachev I.V., Kostinov M.P. Immunotherapy: mechanisms of action and clinical use of pharmacological immunocorrection. Lechashchiy vrach. 2010; 4: 9–19 (in Russian).

21. Kostinov M.P., Solov'eva I.L., eds. Immunomodulators and Vaccination. Moscow: 4Mpress; 2013 (in Russian).

22. Chuchalin A. G., Khokhlova A. L., eds. Federal Guideline on Use of Pharmacological Agents (A Formulary System). The 18th Issue. Moscow: Vidoks; 2017 (in Russian).

23. Kostinov M.P., Kulakova N.A. Immunomodulation and vaccination in COPD patients. LAP Lambert Academic Publishing; 2018.

24. Kostinov M.P., Lavrov V.F. New-generation vaccines for prevention of infectious diseases. The 2nd Updated Edition. Moscow: MDV; 2010.